BioCryst Pharmaceuticals, Inc. (BCRX)
7.58
-0.08
(-1.04%)
USD |
NASDAQ |
Dec 11, 16:00
7.77
+0.19
(+2.51%)
Pre-Market: 08:57
BioCryst Pharmaceuticals Free Cash Flow: 47.64M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Astria Therapeutics, Inc. | -120.32M |
| Hologic, Inc. | 904.70M |
| Johnson & Johnson | 20.46B |
| Viatris, Inc. | 1.614B |
| KalVista Pharmaceuticals, Inc. | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 41.11M |
| Cash from Investing (Quarterly) | 13.57M |
| Cash from Financing (Quarterly) | -58.30M |
| Free Cash Flow Per Share (Quarterly) | 0.1809 |
| Free Cash Flow to Equity (Quarterly) | 95.58M |
| Free Cash Flow to Firm (Quarterly) | 60.67M |
| Free Cash Flow Yield | 2.91% |